ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Minnesota Medical School in collaboration with the American Association for Cancer Research. The University of Minnesota Medical School is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The University of Minnesota Medical School designates this educational activity for a maximum of 27.25
AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE, AND LEARNING OBJECTIVES
The future of cancer prevention relies not only on traditional approaches of prevention and early detection, but also increasingly on new molecular approaches. As the field is rapidly evolving, physicians need continuing education to keep abreast of new developments in order to detect cancer earlier; design models for identifying high-risk patients and populations; tailor prevention strategies for patients with specific genetic profiles; develop preclinical models such as gene targeting/knockout mice for testing chemopreventive agents; identify promising new targets for agent development, and identify the cancer risk of intraepithelial neoplasia (IEN); and use surrogate endpoint biomarkers.
This annual multidisciplinary conference will provide a comprehensive agenda of prevention research education in all scientific disciplines; encourage communication between physicians and patients by educating primary care physicians about known cancer risks, current screening methods and prevention practices; foster collaborations between basic, clinical, epidemiologic, and behavioral cancer prevention researchers; foster public, academic, government, and industry acceptance of cancer prevention science as a major oncologic specialty; and catalyze coordinated, focused, multidisciplinary research efforts that promise to accelerate the future contributions of cancer prevention to science and the public health.
The conference is presented for basic, translational, clinical, epidemiological and behavioral scientists and physician-scientists involved in cancer prevention research and all subdisciplines of biomedical science related to cancer prevention research.
Following this activity, participants should be able to:
- describe the link between the biology of carcinogenesis with its prevention and reversal in pre-invasive stages;
- utilize cancer risk models to identify high-risk patient candidates for chemoprevention, surgical prevention, or lifestyle change(s) to reduce the chance of developing neoplasia;
- critically assess results of clinical trials of cancer preventive drugs and to better explain the risk-benefit issues of, and challenges to, preventive agent development;
- explain the opportunities and controversies surrounding new technologies (for example, proteomics and imaging) for early detection of neoplasia and monitoring treatment effects;
- formulate treatment plans with vaccines and antibiotics for the prophylaxis and treatment of infection (e.g., bacteria, virus)-related neoplasia and for prevention of infection-associated human cancers;
- explain the most recent developments of prevention research related to cancer risk, cancer screening, and cancer prevention to patients; and
- articulate tobacco-control science and public policy and utilize them in both cancer prevention research and practice.
DISCLOSURE STATEMENT
It is the policy of the University of Minnesota Medical School Office of Continuing Medical Education to ensure balance, independence, objectivity and scientific vigor in all of its sponsored educational activities. All participating faculty, course directors, and planning committee members and staff are required to disclose any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. Specific disclosure information for each course faculty will be shared with the audience prior to the faculty’s presentation.
ACKNOWLEDGMENT OF COMMERCIAL SUPPORT
This educational activity has been supported by grants from the National Cancer Institute, NIH, HHS; AstraZeneca; Eli Lilly and Company; Merck; AFLAC, Inc.; the American Cancer Society; Avon Foundation; Cancer Prevention and Research Foundation; Comprehensive Minority Biomedical Branch of the National Cancer Institute; and AACR-Women in Cancer Research.
CLAIMING CME CREDIT
The deadline for the submission of requests for credit for CME has elapsed. Please contact the AACR Office of CME at
cme@aacr.org or (215) 440-9300 with further inquiries.